FDAnews Drug Daily Bulletin

ASPREVA PHARMACEUTICALS ADDED TO THE NASDAQ BIOTECHNOLOGY INDEX

May 23, 2006
A A

Aspreva Pharmaceuticals Corporation, an emerging pharmaceutical company focused on increasing the pool of evidence-based medicines available for patients with less common diseases, announced that effective today, the Company has been added to the NASDAQ Biotechnology Index.
PR Newswire